{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:47Z","timestamp":1787169647118,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cFondo Semilla\u201d of UAG\u2019s Research Directorate"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The effects SARS-CoV-2 inflicts on human physiology, especially in patients who developed COVID-19, can range from flu-like symptoms to death, and although many lives have been lost during the pandemic, others have faced the resolution of aggressive neoplasms that once proclaimed a poor prognosis following traditional treatments. The purpose of this review was to analyze several fortunate case reports and their associated biomolecular pathways to further explore new avenues that might provide oncological treatments in the future of medicine. We included papers that discussed cases in which patients affected by COVID-19 suffered beneficial changes in their cancer status. Multiple mechanisms which elicited a reactivation of the host\u2019s immune system included cross-reactivity with viral antigens and downregulation of neoplastic cells. We were able to identify important cases presenting the resolution\/remission of different aggressive neoplasms, for which most of the time, standard-of-care treatments offered little to no prospect towards a cure. The intricacy of the defense mechanisms humans have adopted against cancer cells through the millennia are still not well understood, but SARS-CoV-2 has demonstrated that the same ruinous cytokine storm which has taken so many lives can paradoxically be the answer we have been looking for to recalibrate the immunological system to retarget and vanquish malignancies.<\/jats:p>","DOI":"10.3390\/ijms24032326","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:53:18Z","timestamp":1674618798000},"page":"2326","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["SARS-CoV-2 as an Oncolytic Virus Following Reactivation of the Immune System: A Review"],"prefix":"10.3390","volume":"24","author":[{"given":"Joao P.","family":"Bounassar-Filho","sequence":"first","affiliation":[{"name":"School of Medicine, Health Sciences Decan, Universidad Autonoma de Guadalajara, Zapopan 45129, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Boeckler-Troncoso","sequence":"additional","affiliation":[{"name":"School of Medicine, Health Sciences Decan, Universidad Autonoma de Guadalajara, Zapopan 45129, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Cajigas-Gonzalez","sequence":"additional","affiliation":[{"name":"School of Medicine, Health Sciences Decan, Universidad Autonoma de Guadalajara, Zapopan 45129, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-9657","authenticated-orcid":false,"given":"Maria G.","family":"Zavala-Cerna","sequence":"additional","affiliation":[{"name":"Immunology Research Laboratory, Health Sciences Decan, Universidad Autonoma de Guadalajara, Zapopan 45129, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or Moderate COVID-19","volume":"383","author":"Gandhi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jinf.2022.08.005","article-title":"Is SARS-CoV-2 an oncogenic virus?","volume":"85","author":"Salas","year":"2022","journal-title":"J. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.omto.2022.06.006","article-title":"Remission of liquid tumors and SARS-CoV-2 infection: A literature review","volume":"26","author":"Shin","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mantwill, K., Klein, F.G., Wang, D., Hindupur, S.V., Ehrenfeld, M., Holm, P.S., and Nawroth, R. (2021). Concepts in Oncolytic Adenovirus Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910522"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Barkhordar, M., Rostami, F.T., Yaghmaie, M., Abbaszadeh, M., Chahardouli, B., and Mousavi, S.A. (2022). Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease-Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease-19. Case Rep. Hematol., 2022.","DOI":"10.1155\/2022\/2603607"},{"key":"ref_6","first-page":"e2020047","article-title":"Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma","volume":"91","author":"Pasin","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e004371","DOI":"10.1136\/jitc-2021-004371","article-title":"Spontaneous tumor regression following COVID-19 vaccination","volume":"10","author":"Sousa","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s13256-021-03127-3","article-title":"Resolution of pituitary microadenoma after coronavirus disease 2019: A case report","volume":"15","author":"Raishan","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjh.17116","article-title":"SARS-CoV-2-induced remission of Hodgkin lymphoma","volume":"192","author":"Challenor","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17588359211011455","DOI":"10.1177\/17588359211011455","article-title":"Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-CoV-2 infection","volume":"13","author":"Ottaiano","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1007\/s00259-021-05275-6","article-title":"Complete remission of follicular lymphoma after SARS-CoV-2 infection: From the \u201cflare phenomenon\u201d to the \u201cabscopal effect\u201d","volume":"48","author":"Sollini","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/16078454.2021.1992117","article-title":"Could COVID-19 induce remission of acute leukemia?","volume":"26","author":"Kandeel","year":"2021","journal-title":"Hematology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clml.2012.06.007","article-title":"Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections","volume":"12","author":"Buckner","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12192-021-01211-7","article-title":"SARS-CoV-2 in patients with cancer: Possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity","volume":"26","author":"Burgio","year":"2021","journal-title":"Cell Stress Chaperones"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12016-014-8424-0","article-title":"The clinical significance of posttranslational modification of autoantigens","volume":"47","author":"Riebeling","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104454","DOI":"10.1016\/j.cellimm.2021.104454","article-title":"SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity","volume":"371","author":"Kim","year":"2022","journal-title":"Cell. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coche.2017.11.006","article-title":"CD8(+) T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy","volume":"19","author":"Rosenberg","year":"2018","journal-title":"Curr. Opin. Chem. Eng."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","article-title":"Activation or exhaustion of CD8(+) T cells in patients with COVID-19","volume":"18","author":"Rha","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/08971900211000691","article-title":"Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection","volume":"35","author":"Meanwatthana","year":"2022","journal-title":"J. Pharm. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/dc.25043","article-title":"PD-L1 immunohistochemical testing: A review with reference to cytology specimens","volume":"51","author":"Layfield","year":"2022","journal-title":"Diagn. Cytopathol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2326\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:56Z","timestamp":1760120096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032326"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032326","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}